200mg Label
Xifaxan Tablet
Product Images NDC 65649-301
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Xifaxan (NDC 65649-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Salix Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
550mg Label
Not available.*
Chemical Structure (Image 01)
Figure 1 (Image 02)
This appears to be a graph representing the proportion of patients without breakthrough HE versus the days post-randomization, with XIFAXAN as the treatment being evaluated. The hazard ratio, 95% CI, and log-rank p-value are also listed.*
Figure 2 (Image 03)
The text provides information regarding the proportion of patients who did not require hospitalization due to HE-related issues. The data is presented in a graph format with different values for each treatment group. The hazard ratio, confidence interval, and log-rank p-value are also reported. The information appears to be related to a clinical trial or study, but without additional context or further information, it is not possible to provide a more specific description.*
Figure-3 (Image 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
